Skip to main content
. 2018 Apr 2;13(4):e0195211. doi: 10.1371/journal.pone.0195211

Fig 5. Characterization of novel tau antibodies in sarkosyl-insoluble human control and AD cortex.

Fig 5

Immunoblots of biochemically sarkosyl-insoluble temporal cortex lysates from post-mortem control (n = 2) and AD (n = 3) cases were probed with the novel tau antibodies (as indicated for each blot) 81A11, 83E4, 94-3A2, 94-3A6, 94-4F1 to determine affinity for tau in human AD. The mobilities of molecular mass markers are shown on the left.